Тема - темы
Coronavirus Infections , Disclosure , Infection Control , Pandemics , Pneumonia, Viral , Politics , Public Policy , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Decision Making , Humans , Infection Control/methods , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Quarantine , SARS-CoV-2 , Time Factors , United States/epidemiologyТема - темы
Coronavirus Infections , Critical Care/organization & administration , Delivery of Health Care/organization & administration , Epidemics , Health Workforce , Pneumonia, Viral , State Medicine/organization & administration , Betacoronavirus , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Equipment and Supplies, Hospital , Hospitals , Humans , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , United Kingdom/epidemiologyТема - темы
Budgets , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Research Support as Topic , Research/economics , COVID-19 , Coronavirus Infections/economics , Education, Graduate/economics , Humans , Pandemics/economics , Pneumonia, Viral/economics , Research Personnel/economics , Universities/economicsТема - темы
Betacoronavirus , Coronavirus Infections/epidemiology , Noncommunicable Diseases/epidemiology , Pneumonia, Viral/epidemiology , Primary Prevention , COVID-19 , Health Policy , Humans , Pandemics , Primary Prevention/legislation & jurisprudence , Primary Prevention/organization & administration , SARS-CoV-2Тема - темы
Agriculture/organization & administration , Coronavirus Infections/epidemiology , Food Supply , Nutrition Policy , Pneumonia, Viral/epidemiology , Agriculture/legislation & jurisprudence , Betacoronavirus , COVID-19 , Humans , Obesity/complications , Obesity/prevention & control , Pandemics , SARS-CoV-2 , United KingdomТема - темы
Coronavirus Infections/epidemiology , Health Promotion , Immunization Schedule , Pneumonia, Viral/epidemiology , Vaccination Coverage/trends , Betacoronavirus , COVID-19 , Child , Child, Preschool , Female , Humans , Infant , Influenza Vaccines/therapeutic use , Measles-Mumps-Rubella Vaccine/therapeutic use , Pandemics , Pertussis Vaccine/therapeutic use , Pregnancy , SARS-CoV-2 , State Medicine , United Kingdom/epidemiologyТема - темы
Communicable Disease Control , Contact Tracing , Coronavirus Infections , Pandemics , Pneumonia, Viral , State Medicine , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Disease Outbreaks , Evidence-Based Medicine , Humans , Laboratories , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Public Health , SARS-CoV-2 , State Medicine/organization & administration , United Kingdom/epidemiology , World Health OrganizationТема - темы
Coronavirus Infections/epidemiology , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , COVID-19 , Caribbean Region/epidemiology , Central America/epidemiology , Chile/epidemiology , Comorbidity , Coronavirus Infections/prevention & control , Humans , Latin America/epidemiology , Mexico/epidemiology , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Politics , PovertyТема - темы
Coronavirus Infections/epidemiology , Coronavirus , Pandemics , Pneumonia, Viral/epidemiology , Africa/epidemiology , Betacoronavirus , COVID-19 , Humans , SARS-CoV-2Тема - темы
Abattoirs , Coronavirus Infections/epidemiology , Meat-Packing Industry , Pneumonia, Viral/epidemiology , Betacoronavirus , COVID-19 , Communicable Disease Control/methods , Coronavirus Infections/prevention & control , Humans , Occupational Exposure , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , SARS-CoV-2Тема - темы
Coronavirus Infections , Decision Making , Health Planning , Health Policy , International Cooperation , Pandemics , Pneumonia, Viral , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Europe/epidemiology , European Union , Ezetimibe, Simvastatin Drug Combination , Forecasting , Guidelines as Topic , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Time Factors , United KingdomТема - темы
Coronavirus Infections/prevention & control , Pandemics/prevention & control , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/prevention & control , Purchasing, Hospital/statistics & numerical data , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/mortality , Coronavirus Infections/virology , England/epidemiology , Equipment and Supplies, Hospital/statistics & numerical data , Equipment and Supplies, Hospital/supply & distribution , Government Employees/legislation & jurisprudence , Humans , Personal Protective Equipment/trends , Pneumonia, Viral/epidemiology , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , SARS-CoV-2 , State Medicine/organization & administrationТема - темы
Coronavirus Infections/physiopathology , Pneumonia, Viral/physiopathology , Age Factors , Aged , Angiotensin-Converting Enzyme 2 , Betacoronavirus , COVID-19 , Comorbidity , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Coronavirus Infections/metabolism , Cytokine Release Syndrome/etiology , Cytokine Release Syndrome/immunology , Cytokine Release Syndrome/physiopathology , Disease Susceptibility , Estrogens/metabolism , Female , Humans , Lymphopenia/etiology , Lymphopenia/immunology , Lymphopenia/physiopathology , Male , Pandemics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pneumonia, Viral/metabolism , SARS-CoV-2 , Severity of Illness Index , Sex Factors , Smoking/epidemiologyРеферат
Numerous cases of pneumonia from a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China during December 2019.We determined the correlations of patient parameters with disease severity in patients with COVID-19.A total of 132 patients from Wuhan Fourth Hospital who had COVID-19 from February 1 to February 29 in 2020 were retrospectively analyzed.Ninety patients had mild disease, 32 had severe disease, and 10 had critical disease. The severe/critical group was older (Pâ<â.05), had a higher proportion of males (Pâ<â.05), and had a greater mortality rate (0% vs 61.9%, Pâ<â.05). The main symptoms were fever (nâ=â112, 84.8%) and cough (nâ=â96, 72.7%). Patients were treated with antiviral agents (nâ=â94, 71.2%), antibiotics (nâ=â92, 69.7%), glucocorticoids (nâ=â46, 34.8%), intravenous immunoglobulin (nâ=â38, 27.3%), and/or traditional Chinese medicine (nâ=â40, 30.3%). Patients in the severe/critical group received mechanical ventilation (nâ=â22, 16.7%) or high-flow nasal can-nula oxygen therapy (nâ=â6, 4.5%). Chest computed tomography (CT) indicated bilateral pneumonia in all patients. Relative to the mild group, the severe/critical group had higher levels of leukocytes, C-reactive protein (CRP), procalcitonin (PCT), D-dimer, B-type natriuretic peptide (BNP), liver enzymes, and myocardial enzymes (Pâ<â.05), and decreased levels of lymphocytes and blood oxygen partial pressure (Pâ<â.05).The main clinical symptoms of patients from Wuhan who had COVID-19 were fever and cough. Patients with severe/critical disease were more likely to be male and elderly. Disease severity correlated with increased leukocytes, CRP, PCT, BNP, D-dimer, liver enzymes, and myocardial enzymes, and with decreased lymphocytes and blood oxygen partial pressure.